—
C+
C+ The full Closelooknet — membership. Open the C+ overview

argenx NV ADR (ARGX) — Technical state

As of 2026-11-04 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 63 out of 100 (momentum 74 · quality 74 · valuation 29), as of 2026-11-05.
  • Signal: Pullback inside an uptrend stack — Trades -0.5% vs the 50-day and +8.8% vs the 200-day average, 13.2% below the 52-week high and +40.7% off the 52-week low. Computed from daily closes. (as of 2026-11-04)
  • Trend: argenx NV ADR trades 0.5% below its 50-day and 8.8% above its 200-day moving average. (as of 2026-11-04)

argenx develops antibody-based therapies for autoimmune disease and sells VYVGART for a rare neuromuscular disorder called generalised myasthenia gravis, plus a related formulation for immune thrombocytopenia and inflammatory nerve disease. Its pipeline includes further FcRn-targeted antibodies and candidates aimed at inflammation, IgA and other immune pathways, developed alone or through partners such as Zai Lab, Halozyme, OncoVerity and AbbVie.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the ARGX overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Pullback inside an uptrend stack

Trades -0.5% vs the 50-day and +8.8% vs the 200-day average, 13.2% below the 52-week high and +40.7% off the 52-week low. Computed from daily closes.

The moving-average stack

Continue: the ARGX chart & overview · quality & forensics · the earnings record · the signal board

FAQ · from the current data · as of 2026-11-04

Quick answers

What is the current Closelooknet signal on ARGX?

Pullback inside an uptrend stack — Trades -0.5% vs the 50-day and +8.8% vs the 200-day average, 13.2% below the 52-week high and +40.7% off the 52-week low. Computed from daily closes. As of 2026-11-04; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is ARGX above its 50-day and 200-day moving averages?

As of 2026-11-04, argenx NV ADR trades -0.5% below its 50-day and +8.8% above its 200-day average, with the 20-day +8.2% away.

How far is ARGX from its 52-week high?

13.2% below the 52-week high and 40.7% above the 52-week low, as of 2026-11-04.

Mentioned on Closelooknet

Where ARGX appears in the diary — 1 piece, newest first. Every link is our own writing.

Dailies

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.